Case Study- Going For Growth: Teva's Global Strategy
1. When Teva moved to a diversification strategy, it had to decide where and how to acquire the capabilities for the new products and markets-build internally, borrow through an alliance, or buy through an acquisition or merger. Under what circumstances, should each of the following be considered?
Build-
Borrow-
Buy-
2. Using the Acquisition Integration matrix, on p. 335 or 339 (depending on your edition), explain which of the four choices for integration would be best for the acquisition of Cephalon.
3. Why was the joint venture with KOWA Pharmaceuticals in Japan a good choice-rather than buying or building capabilities?